Celsion Corporation Gains 36.63%
Thu, May 21, 2020 at 05:30 PM
Celsion Corporation (CLSN:NASDAQ) rocketted at $2.35, a gain of 36.6%. On Wed 20 May 20, CLSN:NASDAQ hit a New 2-Week High of $1.72. The stock got featured on our News Catalysts scanner on Mon 18 May 20 at 01:11 PM in the 'INVESTOR UPDATE' category. From Wed 06 May 20, the stock recorded 60.00% Up Days and 72.73% Green Days
About Celsion Corporation (CLSN:NASDAQ)
Celsion Corp is a fully-integrated oncology drug development company. The Company is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.
Top 10 Gainers:
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 160.28%
- GNRS (GNRS:NASDAQ), 100%
- Surface Oncology, Inc. (SURF:NASDAQ), 53.35%
- Seneca Biopharma, Inc. (SNCA:NASDAQ), 49.69%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 46.19%
- Celsion Corporation (CLSN:NASDAQ), 36.63%
- Aurora Cannabis Inc. (ACB:NYSE), 36.47%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 35.03%
- Nabors Industries Ltd. (NBR:NYSE), 33.36%
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 31.1%